1 |
Prados MD, Wilson CB. Neoplasms of the centralnervous system. In: Holland JF, Frei F, Bast RC,Kufe DW, Morton DL, Weichselbaum RR eds.Cancer medicine, vol. 1. Baltimore: Williams andWilkins; 1997. p. 1471-514.
|
2 |
Di Chiro G, Delapaz RL, Brooks RA, Sokoloff L,Kornblith PL, Smith BH et al. Glucose utilizationof cerebral glioma measured by F-18 and PET.Neurology 1982;32:1323-29.
|
3 |
Barker FG, Chang SM, Valk PE, Pounds TR,Prados MD. F-18-fluorodeoxyglucose uptake andsurvival of patients with suspected recurrentmalignant glioma. Cancer 1997;79:115-26.
|
4 |
Hustinx R, Alavi A. SPECT and PET imaging ofbrain tumors. Neuroimag Clin North Amer1999;9(4):751-66.
|
5 |
Langleben DD and Segall GM. PET indifferentiation of recurrent brain tumor fromradiation injury. J Nucl Med 2000;41:1861-7.
|
6 |
Derlon JM, Chapon F, Noel MH, Khouri S, BenaliK, Petit-Taboue MC, et al. Non-invasive grading ofoligodendrogliomas: correlations between in vivometabolic pattern and histopathology. Eur J NuclMed 2000;27:778-87.
|
7 |
Weber WA, Wester HI, Grosu AL, Herz M,Dzewas B, Feldmann HJ, et al. O-(2-C8F]fluoroethyl)L-tyrosine and L-[methyl-11Clmethionine uptake inbrain tumours: initial results of a comparativestudy. Eur J Nucl Med 2000;27(5):542-49.
|
8 |
Herholz K, Pietrzyk U, Voges J, Schroder R,Halber M, Treuer H, et al. Correlation of glucoseconsumption and tumor cell density in astrocytomas.A stereotactic PET Study. J Neurosurg 1993;79(6):853-8.
|
9 |
Holzer T, Herholz K, Jeske J, Heiss WD.FDG-PET as a prognostic indicator inradiochemotherapy of glioblastoma. J Comut AssistTomogr 1993;17:681-7.
|
10 |
Kaschten B, Stevenaert A, Sadzot B, Deperez M,Degueldre C, Fiore GD, et al. Preoperativeevaluation of 54 gliomas by PET withFluorine-18-fluorodeoxyglucose and/or Carbon-llmethionine.J Nucl Med 1998;39(5):778-85.
|
11 |
Ogawa T, Kanno I, Shishido F, Inugami A, HigasoS, Fujita H, et al. Clinical value of PET witheSF]-fluorodeoxyglucose and l-methyl-L'Cj-methioninefor the diagnosis of recurrent brain tumor andradiation injury. Acta Radiologica 1991;32:197-202.
|
12 |
Ogawa T, Kanno I, Hatazawa J, Inugami A, FujitaH, Shimosegawa E, et al. Methionine PET forfollow-up of radiation therapy of primary lymphomaof the brain. Radiographies 1994;14:101-10.
|
13 |
Fulham MJ, Melisi JW, Nishimiya J, Dwyer AJ, DiChiro G. Neuroimaging of juvenile pilocyticastrocytomas: An enigma. Radiology 1993;189:221-5.
|
14 |
Goldman S, Levivier M, Pirotte B, Brucher JM,Wikler D, Damhaut P, et al. Regional methionineand glucose uptake in high-grade gliomas: Acomparative study on PET-guided stereotacticbiopsy. J Nucl Med 1997;38:1459-62.
|
15 |
De Witte 0, Hildebrand J, Luxen A, Goldman S.Acute effect of carnustine on glucose metabolism inbrain and glioblastoma. Cancer 1994;74:2836-42.
|
16 |
Kubota R, Kubota K, Yamada S, Tada M,Takahashi T, Iwada K, et al. Methionine uptake bytumor tissue: a microautoradiographic comparisonwith FDG. J Nucl Med 1995;36:484-92.
|
17 |
De Witte 0, Levivier M, Violon P, Salmon I,Darnhaut P, Wikler D, et al. Prognostic value ofpositron emission tomography with [18F]fluoro-2deoxy-D-glucose in the low-grade glioma.Neurosurgery 1996;39(3):470-7.
|
18 |
Hara T, Kosaka N, Shinoura N, Kondo T. PETimaging of brain tumor with [methyl-C-ll]choline.J Nucl Med 1997;38:842-7.
|
19 |
Nuutinen J, Sonninen P, Lehikoinen P, Sutinen E,Valavaara R, Eronen E, et al. Radiotherapytreatment planning and long-term follow-up withelClmethionine PET in patients with low-grade astrocytoma. Int J Radiation Oncology Bio Phys2000;48(1):43-52.
|
20 |
Chung J-K, Kim YK, Kim SK, Lee J, Paek S, YeoS, et al. Usefulness of llC-methionine PET in theevaluation of brain tumors that are hypo- orisometabolism on l8F_FDG PET. Eur J Nucl Med2002;29: 176-82.
|
21 |
Marriott CJ, Throstad W, Akabani G, Brown MT,McLendon RE, Hanson MW, et al. Locally increased uptake of fluorine-18-fluorodeoxyg1ucoseafter intracavitary administration of iodine-131-labeledantibody for primary brain tumors. J Nucl Med1998;39:1376-80.
|